High density lipoprotein metabolism

Similar documents
Lipid/Lipoprotein Structure and Metabolism (Overview)

Lipoproteins Metabolism

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism

Chapter VIII: Dr. Sameh Sarray Hlaoui

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Pathophysiology of Lipid Disorders

Lipids digestion and absorption, Biochemistry II

CETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins


LIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE


Nature Genetics: doi: /ng.3561

HDL : A Treatment Target? ESC Paris M. John Chapman Ph.D., D.Sc., FESC. President, European Atherosclerosis Society

Metabolism and Atherogenic Properties of LDL

Cholesterol Metabolism

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

Regulating Hepatic Cellular Cholesterol

Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors

Summary and concluding remarks

Niacin Metabolism: Effects on Cholesterol

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

PPAR history of research

Lipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel

Chapter (5) Etiology of Low HDL- Cholesterol

Lipoprotein Pathophysiology. Lipoprotein Pathophysiology

Cholesterol and its transport. Alice Skoumalová

Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes

Cholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT

Lipid metabolism in familial hypercholesterolemia

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL

STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS. R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017

Mendelian disorders refer to diseases caused by mutations. Review. Mendelian Disorders of High-Density Lipoprotein Metabolism

N-3 Fatty Acids Non-HDL-Cand LDL-C Thomas Dayspring MD, FACP

The role of HDL-cholesterol in preventing atherosclerotic disease

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

HDL and Its Galaxy of Proteins: What Do they Do? Jay Heinecke, University of Washington

ESC Congress 2011 Wednesday August 31st 2011

Contributions in Medicine: Will CETP Inhibition Contribute Toward Reduction of Cardiovascular Risk?

Supplemental Material. Results

Hypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002

Dipartimento di Scienze Cliniche Luigi Sacco SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE BIOCHIMICHE, NUTRIZIONALI E METABOLICHE

Lipid Metabolism in Familial Hypercholesterolemia

Prof. John Chapman, MD, PhD, DSc

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

TC =96; HDL-C = 21; Non-HDL-C = 75; LDL-C: less than 10 TG: 357; VLDL-C = 71; TG/HDL-C: 17 TC/HDL-C = 4.5

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

Chapter 1 GENERAL INTRODUCTION. 1.1 Lipoproteins and Lipid Metabolism

Placental Transport in Pathologic Pregnancies

Lipids, lipoproteins and cardiovascular disease

Zuhier Awan, MD, PhD, FRCPC

review Cell cholesterol efflux: integration of old and new observations provides new insights

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Cholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss

Moh Tarek + Suhayb. Tamara Al-Azzeh + Asmaa Aljeelani ... Faisal

A Study of Omega-3 Fatty Acid. Therapy in Patients with. Nephrotic Syndrome

High density lipoprotein metabolism

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

CHAPTER 1. General Introduction

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Reverse Cholesterol Transport and Atherosclerosis

Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL

ANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD

METABOLISM of ADIPOSE TISSUE

Lipidaholics Anonymous Case 2012;13:(1);284 Explaining the unexplainable LDL- P

Suppl. Table 1: CV of pooled lipoprotein fractions analysed by ESI-MS/MS

Reduction in Serum Lecithin:Cholesterol Acyltransferase Activity Prior to the Occurrence of Ketosis and Milk Fever in Cows

Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?

INTERNATIONAL JOURNAL OF BIOASSAYS ISSN: X CODEN: IJBNHY OPEN ACCESS

Cellular control of cholesterol. Peter Takizawa Department of Cell Biology

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins

Thematic review series: The Immune System and Atherogenesis

*Address Correspondence to Päivi Pajukanta, MD, PhD, Associate Professor, Department of

The Role of Apolipoprotein CIII in Coronary Artery Disease. Disclosures

Anti Hyperlipidemic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

LIPIDS OF BLOODSTREAM

LIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI

Introduction REVIEW. M. John Chapman*, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush. Keywords

Metabolism and Protective Properties of HDL

Lipids Board Review. Ira Goldberg, MD New York University School of Medicine. Which of the following is the best initial therapy choice?

CHM333 LECTURE 34: 11/30 12/2/09 FALL 2009 Professor Christine Hrycyna

The Addition of Ezetimibe to Statin therapy in. Patients with Homozygous Familial. Hypercholesterolaemia


By: Dr Hadi Mozafari 1

Central role of apociii

Introduction Hyperlipidemia hyperlipoproteinemia Primary hyperlipidemia (Familial) Secondary hyperlipidemia (Acquired)

Lipoprotein Particle Profile

Plasma lipid transfer proteins

Metabolic defects underlying dyslipidemia in abdominal obesity

Alow level of HDL cholesterol is an important cardiovascular

Thematic Review Series: Genetics of Human Lipid Diseases. Genetic causes of high and low serum HDL-cholesterol

Transcription:

High density lipoprotein metabolism

Lipoprotein classes and atherosclerosis Chylomicrons, VLDL, and their catabolic remnants Pro-atherogenic LDL HDL Anti-atherogenic

Plasma lipid transport Liver VLDL FC FC TG FFA TG LPL LDL FFA Adipose and other tissues Adipose tissue TP TG Liver LDL receptor LDL receptor Bile HDL TG LCAT ABCA1 FC New synthesis Cell in peripheral tissue

HDL and cardiovascular disease

Hazard Ratio Coronary heart disease and HDL-C 3.5 3.0 2.5 2.0 N = 302,430 Adjusted for age and gender Adjusted for multiple factors 1.5 1.0 0.8 0.75 1.0 1.25 1.5 1.75 2.0 HDL-C (mmol/l) The Emerging Risk Factors Collaboration. JAMA 2009;302:1993-2000.

What are HDLs?

Structure of HDL Surface monolayer of phospholipids and free cholesterol apoa-i apoa-ii Hydrophobic core of triglyceride and cholesteryl esters

HDL are heterogeneous COMPOSITION APOLIPOPROTEINS ApoA-I, apoa-ii, apoa-iv, apoe, others LIPIDS TG,, FC, PL SIZE: 7.5-15 nm SHAPE: spherical, discoidal CHARGE: prebeta, alpha

HDL Charge and shape Lipid-poor apoa-i Prebeta mobility Discoidal Prebeta mobility Spherical Alpha mobility

HDL Subpopulations PARTICLE SHAPE APOLIPOPROTEIN COMPOSITION Discoidal Spherical A-I HDL A-I/A-II HDL PARTICLE SIZE Lipid-poor apoa-i HDL 2b HDL 2a HDL 3a HDL 3b HDL 3c

This HDL heterogeneity is the result of activity of several factors that assemble and remodel HDL in plasma

Origin of apoa-i LIVER INTESTINE Chylomicrons Lipid-poor apoa-i Lipolysis

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

Lipidation of apoa-i Lipid-poor apoa-i Cell membrane ABCA-1 phospholipid, cholesterol Discoidal HDL

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

LCAT (lecithin:cholesterol acyltransferase) LCAT catalyses the reaction: phosphatidylcholine lysophosphatidylcholine unesterified cholesterol cholesteryl ester

LCAT The LCAT reaction is responsible for most of the cholesteryl esters circulating in plasma HDLs are the preferred substrates for LCAT LCAT is activated by apoa-i, apoa-iv, apoe LCAT NOT activated by apoa-ii

Role of LCAT in formation of spherical HDL Liver Intestine Free cholesterol transferred from cell membranes (including liver and intestine) apoa-i free cholesterol LCAT cholesteryl esters Discoidal HDL Spherical HDL

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

Role of TP in plasma cholesterol transport Liver LDL-R SR-B1 FC SR-B1 TP VLDL/LDL Bile HDL LCAT FC Extrahepatic Tissues (including the artery wall Free Cholesterol

Shuttle mechanism HDL TP TP TRL TG TG TG TG TG TP TG TP TG LDL Barter et al; Biochem J. 1982; 208:1. Swenson et al. J. Biol. Chem. 1988; 263:5150. Tall. J. Lipid Res.1993; 34:1255.

TP plays a major role in remodelling of HDL, especially when acting in the presence of hepatic lipase

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

HEPATIC LIPASE Hepatic lipase catalyses the hydrolysis of triglyceride and phospholipids in HDL Remodelling of HDL by hepatic lipase is most dramatic when linked to activity of TP

Role of TP and hepatic lipase in the remodelling of HDL HDL TGR-LP TG TP TG HDL TG Lipid-free/poor apoa-i TG HL FFA TG Excretion through kidney Small, dense HDL Rye et al Atherosclerosis, 1999,145:227 Rye et al Arterioscler Thromb Vasc Biol, 2004, 24: 421.

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

PLTP (phospholipid transfer protein) PLTP catalyses the transfer of phospholipids between plasma lipoproteins PLTP also remodels HDL

Remodelling of AI-HDL by PLTP PLTP PLTP PLTP lipid-poor apoa-i

Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

SRB1 (scavenger receptor type B1) SRB1 promotes the selective hepatic uptake of HDL cholesteryl esters SRB1 thus also remodels HDL

Remodelling of AI-HDL by SRB1 Liver Lipid-poor apoa-i SRB1 TG Larger HDL TG Smaller HDL

Apolipoprotein-specific HDL apoa-i apoa-i TG TG apoa-ii Spherical AI-HDL Spherical AI/AII-HDL

Origin of AII-HDL Secretion LIVER Lipid-poor apoa-ii phospholipids from cell membranes Discoidal AII-HDL

LCAT-mediated formation of spherical AI/AII-HDL Discoidal AI-HDL LCAT Spherical AI-HDL LCAT Fusion Spherical AI/AII-HDL TG LIVER Discoidal AII-HDL

Remodelling of HDL generates lipid-poor apoa-i

Remodelling of HDL generates lipid-poor apoa-i TG TP HL PLTP SRB1 TG Lipid-poor apoa-i

Fate of lipid-poor apoa-i Lipid-poor apoa-i Acquire PL from cells (via ABCA1) to form discoidal HDL Discoidal AI-HDL Incorporation into spherical AI-HDL Excretion through kidney Small, spherical AI-HDL LCAT Large, spherical AI-HDL

Cycling of apoa-i between HDL and a HDL TP HL PLTP SRB1 TG lipid-poor pool Lipid-poor apoa-i Excretion through kidney Discoidal HDL TG UC LCAT TG

Functions of HDL

Role of HDL in promoting efflux of cholesterol from cells

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i ABCA1 FC,PL

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i ABCA1 FC,PL Discoidal HDL

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL ABCA1 ABCA1 SR-B1 FC,PL FC

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT ABCA1 ABCA1 SR-B1 FC,PL FC Small spherical HDL

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT ABCA1 ABCA1 SR-B1 FC,PL FC Small spherical HDL Diffusion SR-B1 ABCG1 FC

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT Small spherical HDL LCAT ABCA1 ABCA1 SR-B1 Diffusion SR-B1 ABCG1 FC,PL FC FC Larger spherical HDL

Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT Small spherical HDL LCAT ABCA1 ABCA1 SR-B1 Diffusion SR-B1 ABCG1 FC,PL FC FC Larger spherical HDL Diffusion SR-B1 ABCG1 FC

Protective properties of HDLs Promote cholesterol efflux from macrophages Anti-oxidant properties Anti-thrombotic properties Anti-inflammatory properties Improve endothelial function Promote endothelial repair Improve glycemic control Other

Conclusions The concentration of HDL-C correlates inversely with CV risk

Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect

Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment

Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition

Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition HDL particles are extensively remodelled in plasma by a variety of proteins and enzymes

Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition HDL particles are extensively remodelled in plasma by a variety of proteins and enzymes Deficiencies of these remodelling factors result in major changes to HDL particles

Unanswered questions Q. Which HDL subpopulations (if any) protect against CV disease? Answer: We do not know Q. Which (if any) of the known HDL functions protect against CV disease? Answer: We do not know Answers to these questions require much more research